Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118444) titled 'Study on the impact of Canagliflozin combined with chemotherapy on the outcomes of patients with pulmonary tuberculosis and diabetes mellitus comorbidity' on Feb. 5.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Tongji University Affiliated Shanghai Pulmonary Hospital
Condition:
Pulmonary Tuberculosis
Intervention:
Experimental group:Use canagliflozin to lower blood sugar
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-02-15
Target Sample Size: Experimental group:30;Control group:30;
Countries of Recruitment:
China
To know more, ...